Biocorp and Novo Nordisk join forces for digital diabetes health
Biocorp and Novo Nordisk are collaborating to develop and distribute a smart add-on device for the Novo Nordisk FlexTouch pen. Mallya, a Bluetooth-enabled smart add-on
Biocorp and Novo Nordisk are collaborating to develop and distribute a smart add-on device for the Novo Nordisk FlexTouch pen. Mallya, a Bluetooth-enabled smart add-on
Walmart has launched the first-ever private brand analogue insulin in the United States, offering customers significant price savings without compromising quality. Manufactured by Novo Nordisk,
A look at a global initiative – Cities Changing Diabetes – driven by Novo Nordisk in association with many partners, both internationally and locally. It
An implantable device containing insulin-producing cells to help treat Type 1 diabetes has moved closer to reality. Underpinned by JDRF-funded research at the University of
A once-weekly basal insulin is in development to help treat Type 2 diabetes. Researchers suggest that reducing the frequency of basal insulin injections might help
The first GLP-1 agonist pill for Type 2 diabetes has been approved by the European Medicines Agency (EMA). Rybelsus (known as oral semaglutide in clinical trials) is a once-daily
A new study in mice has found that a targeted combination of drugs can restore beta cell function and achieve beta-cell redifferentiation, which could eventually
Massachusetts Institute of Technology (MIT) engineers and scientists from Novo Nordisk have designed a drug capsule that can carry insulin or other protein drugs and
In an article for the New York Times, Donald McNeil reported, “With insulin prices skyrocketing and substantial shortages developing in poorer countries, the World Health
New diabetes treatments can be hard to keep track of. Here we take a look at some of the newer treatments and trials for diabetes.